Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06337552). This is a study registration, not published results. Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute. Recruitment status: ACTIVE_NOT_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 39 participants (ACTUAL). Conditions: Rectal Cancer, Non-Small Cell Lung Cancer. Interventions: OTHER: FEED-FF; OTHER: Standard of Care (SUC). Primary outcome measures: Effects of the FEED-FF diet on clinical response to chemoradiation (Rectal Cancer Patients) , At Baseline and Up to 12.5 Weeks; Effects of the FEED-FF diet on clinical response to immunotherapy (Lung Cancer Patients) , At Baseline and Up to 12.5 Weeks; Effects of FEED-FF diet on the gut microbiome , At Baseline, Week 6.5 and Up to 12.5 Weeks; Effects of FEED-FF diet on local immune-related biomarkers , At Baseline and Up to 12.5 Weeks; Effects of FEED-FF diet on quality of life , At Baseline, Week 6.5 and Up to 12.5 Weeks; Efficacy of the FEED-FF intervention , At Baseline, Week 6.5 and Up to 12.5 Weeks; Feasibility of the FEED-FF intervention , At Baseline, Week 6.5 and Up to 12.5 Weeks. Brief summary: The purpose of the study is to evaluate the feasibility and acceptability of a dietary intervention (FEED-FF) that includes fermented foods (FF), among locally advanced rectal cancer patients and non-small cell lung cancer (NSCLC) patients, and to explore whether this diet can improve outcomes in rectal cancer patients receiving chemoradiation and NSCLC patients receiving immunotherapy.